From Big Pharma To Small Startup — A Chief Medical Officer's Perspective On Diversity & Inclusion
Source: Life Science Leader
In this executive virtual roundtable (EVR) segment, Peng Lu, M.D., Ph.D., chief medical officer at Pharvaris, a clinical-stage company focused on bringing oral bradykinin B2-receptor antagonists to patients, provides her perspective on diversity and inclusion (D&I) at Big Pharma, along with what currently experiencing at a Netherlands based startup. The full EVR, “Making Diversity & Inclusion A Best Business Practice,” can be viewed here.
This website uses cookies to ensure you get the best experience on our website. Learn more